Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats
Cancer Chemotherapy and Pharmacology · 04.06.2026 · 96 (1)
DOI: 10.1007/s00280-026-04908-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 04.06.2026. Verfasst von Sonia Bisht und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy (AIP), Amity University Uttar Pradesh, Noida Campus, Noida, India. Hauptthemen laut MEDLINE: beta-Glucans, Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Pharmacy (AIP), Amity University Uttar Pradesh, Noida Campus, Noida, India.
- Amity Institute of Pharmacy (AIP), Amity University Uttar Pradesh, Noida Campus, Noida, India. sgupta23@amity.edu.
Zitieren
APA
Bisht, S., & Gupta, S. (2026). Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04908-7
Vancouver
Bisht S, Gupta S. Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04908-7
BibTeX
@article{Bisht2026,
author = {Bisht, Sonia and Gupta, Sangeetha},
title = {Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2026},
volume = {96},
number = {1},
doi = {10.1007/s00280-026-04908-7}
}
EUVIMED